Timothy Coughlin - 17 May 2023 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role: Director
Signature: /s/ Nancy E. Denyes, as Attorney-in-Fact
Issuer symbol: ATYR
Transactions as of: 17 May 2023
Net transactions value: $0
Form type: 4
Filing time: 19 May 2023, 16:27:18 UTC
Previous filing: 28 Apr 2023
Next filing: 07 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LIFE	Common Stock	Gift	$0	-6,000	-100%	$0.000000^*	0	17 May 2023	Direct
transaction	LIFE	Common Stock	Gift	$0	+6,000		$0.000000	6,000	17 May 2023	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LIFE	Stock Option (right to buy)	Award	$0	+12,000		$0.000000	12,000	17 May 2023	Common Stock	12,000	$2.52	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.
F2	The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.